Axillary artery access considerations in Impella 5.5 insertion: Insights from exclusive axillary approach for successful support

IF 2.2 3区 医学 Q3 ENGINEERING, BIOMEDICAL Artificial organs Pub Date : 2024-09-17 DOI:10.1111/aor.14861
Shazli Khan, Ameesh Isath, Vasiliki Gregory, Guy Elgar, Avi Levine, Syed A. Haidry, Hasan Ahmad, Sooyun Caroline Tavolacci, Junichi Shimamura, Suguru Ohira
{"title":"Axillary artery access considerations in Impella 5.5 insertion: Insights from exclusive axillary approach for successful support","authors":"Shazli Khan, Ameesh Isath, Vasiliki Gregory, Guy Elgar, Avi Levine, Syed A. Haidry, Hasan Ahmad, Sooyun Caroline Tavolacci, Junichi Shimamura, Suguru Ohira","doi":"10.1111/aor.14861","DOIUrl":null,"url":null,"abstract":"BackgroundThe Impella 5.5® is commonly inserted via the axillary artery (AX) in patients with cardiogenic shock. The right AX has traditionally been preferred to avoid crossing the aortic arch, and a minimum diameter of 7 mm has been recommended to accommodate the device (21 Fr). There is limited data on choice of laterality of access and AX size required, both in terms of technicality of the procedure as well as outcomes.MethodsWe performed a single‐center retrospective cohort analysis of patients who underwent Impella 5.5® implantation between December 2020 and February 2024 (<jats:italic>N</jats:italic> = 75). Data including demographics and outcomes were stratified both by diameter (small, &lt;7 mm vs. normal, ≥7 mm) and laterality of access (right vs. left). Adverse events included stroke, limb ischemia, procedural bleeding or infection, and unplanned explant due to complications. Delivery time was defined as time from advancing the first wire to activation of the device.ResultsAX approach was attempted in all (<jats:italic>N</jats:italic> = 74) but one requiring innominate access, with a technical success rate of 95.9% (<jats:italic>N</jats:italic> = 71/74). The mean age was 58.8 ± 13.3 years, with 81.1% males. The median delivery time was 7.0 (25th, 75th percentiles: 4.0, 11.5) min with a median support duration of 13 (7.7, 24) days. Ten patients (13.5%) had a small AX, with a mean diameter of 6.3 ± 0.5 mm and were more likely to be younger compared to the normal AX group. Fifty‐nine patients (79.7%) had insertion via the right AX. Median delivery time was comparable across all groups (small, 5.4 [3.5, 10.9] vs. normal, 7 [4.0, 12.1] min, <jats:italic>p</jats:italic> = 0.59) and (right, 10.4 [5.3, 15.2] vs. left, 6 [3.7, 10.4] min, <jats:italic>p</jats:italic> = 0.35). There was no difference between the rates of stroke, ischemia, bleeding, or infection when comparing by size or laterality. Survival to discharge was 59.5%, with 21.1% mortality on support, all in patients with a normal AX diameter, but with no difference between right versus left.ConclusionIn our study, laterality and a small diameter of AX access did not affect outcomes of Impella 5.5®, with a similar safety profile.","PeriodicalId":8450,"journal":{"name":"Artificial organs","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Artificial organs","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1111/aor.14861","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundThe Impella 5.5® is commonly inserted via the axillary artery (AX) in patients with cardiogenic shock. The right AX has traditionally been preferred to avoid crossing the aortic arch, and a minimum diameter of 7 mm has been recommended to accommodate the device (21 Fr). There is limited data on choice of laterality of access and AX size required, both in terms of technicality of the procedure as well as outcomes.MethodsWe performed a single‐center retrospective cohort analysis of patients who underwent Impella 5.5® implantation between December 2020 and February 2024 (N = 75). Data including demographics and outcomes were stratified both by diameter (small, <7 mm vs. normal, ≥7 mm) and laterality of access (right vs. left). Adverse events included stroke, limb ischemia, procedural bleeding or infection, and unplanned explant due to complications. Delivery time was defined as time from advancing the first wire to activation of the device.ResultsAX approach was attempted in all (N = 74) but one requiring innominate access, with a technical success rate of 95.9% (N = 71/74). The mean age was 58.8 ± 13.3 years, with 81.1% males. The median delivery time was 7.0 (25th, 75th percentiles: 4.0, 11.5) min with a median support duration of 13 (7.7, 24) days. Ten patients (13.5%) had a small AX, with a mean diameter of 6.3 ± 0.5 mm and were more likely to be younger compared to the normal AX group. Fifty‐nine patients (79.7%) had insertion via the right AX. Median delivery time was comparable across all groups (small, 5.4 [3.5, 10.9] vs. normal, 7 [4.0, 12.1] min, p = 0.59) and (right, 10.4 [5.3, 15.2] vs. left, 6 [3.7, 10.4] min, p = 0.35). There was no difference between the rates of stroke, ischemia, bleeding, or infection when comparing by size or laterality. Survival to discharge was 59.5%, with 21.1% mortality on support, all in patients with a normal AX diameter, but with no difference between right versus left.ConclusionIn our study, laterality and a small diameter of AX access did not affect outcomes of Impella 5.5®, with a similar safety profile.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Impella 5.5 植入术中的腋动脉入路注意事项:腋窝独家方法对成功支持的启示
背景Impella 5.5® 通常经由心源性休克患者的腋动脉 (AX) 插入。传统上首选右侧腋动脉,以避免穿越主动脉弓,并建议最小直径为 7 毫米以容纳该装置 (21 Fr)。我们对 2020 年 12 月至 2024 年 2 月期间接受 Impella 5.5® 植入术的患者(N = 75)进行了单中心回顾性队列分析。包括人口统计学和结果在内的数据按直径(小,<7 mm 与正常,≥7 mm)和入路侧位(右侧与左侧)进行了分层。不良事件包括中风、肢体缺血、手术出血或感染以及因并发症导致的计划外切除。结果除一名需要从髂内入路的患者外,其余患者(N = 74)均尝试了AXT入路,技术成功率为95.9%(N = 71/74)。平均年龄为 58.8 ± 13.3 岁,81.1% 为男性。中位分娩时间为 7.0 分钟(第 25、75 百分位数:4.0、11.5 分钟),中位支持时间为 13 天(7.7、24 天)。10名患者(13.5%)的AX较小,平均直径为(6.3 ± 0.5)毫米,与正常AX组相比,他们更年轻。59名患者(79.7%)通过右侧AX插入。各组的中位分娩时间相当(小型组为 5.4 [3.5, 10.9] 分钟,正常组为 7 [4.0, 12.1] 分钟,P = 0.59)和(右侧组为 10.4 [5.3, 15.2] 分钟,左侧组为 6 [3.7, 10.4] 分钟,P = 0.35)。按大小或侧位比较,中风、缺血、出血或感染的发生率没有差异。出院后的存活率为 59.5%,21.1% 的患者在支持过程中死亡,所有患者的 AX 直径都正常,但右侧和左侧没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Artificial organs
Artificial organs 工程技术-工程:生物医学
CiteScore
4.30
自引率
12.50%
发文量
303
审稿时长
4-8 weeks
期刊介绍: Artificial Organs is the official peer reviewed journal of The International Federation for Artificial Organs (Members of the Federation are: The American Society for Artificial Internal Organs, The European Society for Artificial Organs, and The Japanese Society for Artificial Organs), The International Faculty for Artificial Organs, the International Society for Rotary Blood Pumps, The International Society for Pediatric Mechanical Cardiopulmonary Support, and the Vienna International Workshop on Functional Electrical Stimulation. Artificial Organs publishes original research articles dealing with developments in artificial organs applications and treatment modalities and their clinical applications worldwide. Membership in the Societies listed above is not a prerequisite for publication. Articles are published without charge to the author except for color figures and excess page charges as noted.
期刊最新文献
Recognition of psychological comorbidity and psychotherapeutic treatment status of ventricular assist device patients. Concomitant tricuspid valve surgery in patients with significant tricuspid regurgitation undergoing left ventricular assist device implantation: A systematic review and meta-analysis. Monitoring Berlin Heart EXCOR by computer vision: A preliminary implementation and evaluation. High-intensity interval training with functional electrical stimulation cycling for incomplete spinal cord injury patients: A pilot feasibility study. Design and simulation of a microfluidics-based artificial glomerular ultrafiltration unit to reduce cell-induced fouling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1